The transmembrane protein sarcolipin regulates calcium storage in the sarcoplasmic reticulum of skeletal and cardiac muscle cells by modulating the activity of sarco(endo)plasmic reticulum Ca 2؉ -ATPases (SERCAs). The highly conserved C-terminal region ( 27 RSYQY-COOH) of sarcolipin helps to target the protein to the sarcoplasmic reticulum membrane and may also participate in the regulatory interaction between sarcolipin and SERCA. Here we used solid-state NMR measurements of local protein dynamics to illuminate the direct interaction between the Tyr 29 and Tyr 31 side groups of sarcolipin and skeletal muscle Ca 2؉ -ATPase (SERCA1a) embedded in dioleoylphosphatidylcholine bilayers. Further solidstate NMR experiments together with functional measurements on SERCA1a in the presence of NAc-RSYQY, a peptide representing the conserved region of sarcolipin, suggest that the peptide binds to the same site as the parent protein at the luminal face of SERCA1a, where it reduces V max for calcium transport and inhibits ATP hydrolysis with an IC 50 of ϳ200 M. The inhibitory effect of NAc-RSYQY is remarkably sequence-specific, with the native aromatic residues being essential for optimal inhibitory activity. This combination of physical and functional measurements highlights the importance of aromatic and polar residues in the C-terminal region of sarcolipin for regulating calcium cycling and muscle contractility.Normal physiological control of muscle contractility depends on the strict regulation of intracellular calcium cycling (1). Muscle relaxation is coupled to the reuptake of Ca 2ϩ by the sarcoplasmic reticulum (SR), 2 driven by the sarco(endo)plasmic reticulum Ca 2ϩ -ATPase (SERCA), a 110-kDa membraneembedded ion pump that maintains a 10,000-fold Ca 2ϩ concentration gradient across the SR membrane (2). The cardiac isoform of SERCA (SERCA2a) associates reversibly with the pentameric transmembrane protein phospholamban (PLB) in the SR membrane resulting in a transitory inhibition of calcium transport into the SR, which is essential for efficient muscle contraction. Inhibition of SERCA2a is relieved during muscle relaxation as a result of phosphorylation of PLB by cAMP-dependent protein kinases in response to -adrenergic stimulation.Sarcolipin (SLN) is a 31-amino acid PLB homologue that co-expresses and co-localizes with the fast twitch skeletal muscle (SERCA1a) isoform of Ca 2ϩ -ATPase and, to a lesser extent, with SERCA2a in cardiac cells (3-5). SLN causes a decrease in the apparent affinity of SERCA enzymes for calcium, but its effect on V max is less clear, with some studies noting an inhibitory effect and others showing a stimulatory response (6, 7). Expression of SLN in cardiac tissue is low in humans and predominates in the atria, whereas PLB levels are higher and localized in the ventricles, but there is mounting evidence that SLN plays a role in regulating calcium cycling in healthy and compromised heart muscle (10 -13). Co-expression of SERCA2a with SLN and PLB enhances the inhibition of calcium transport by S...